Last reviewed · How we verify
TA-CD Vaccination
At a glance
| Generic name | TA-CD Vaccination |
|---|---|
| Also known as | An aluminium hydroxide gel adjuvant in a saline solution. |
| Sponsor | Baylor College of Medicine |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Therapeutic Cocaine Vaccine: Human Laboratory Study (PHASE2)
- Multisite Controlled Trial of Cocaine Vaccine (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TA-CD Vaccination CI brief — competitive landscape report
- TA-CD Vaccination updates RSS · CI watch RSS
- Baylor College of Medicine portfolio CI